Muramyl dipeptide activation of nucleotide-binding oligomerization domain 2 protects mice from experimental colitis
Tomohiro Watanabe(National Institutes of Health), Warren Strober(National Institutes of Health)
Cited by 328
Related Papers
Cell Contact–Dependent Immunosuppression by Cd4+Cd25+Regulatory T Cells Is Mediated by Cell Surface–Bound Transforming Growth Factor β
|The Journal of Experimental Medicine|2001|1.6k
Anti–Interleukin-12 Antibody for Active Crohn's Disease
|New England Journal of Medicine|2004|853
Experimental Models of Inflammatory Bowel Diseases
|Cellular and Molecular Gastroenterology and Hepatology|2015|704
Loss-of-function CARD8 mutation causes NLRP3 inflammasome activation and Crohn’s disease
|Journal of Clinical Investigation|2018|111